Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Asset Writedowns and Impairment (2022 - 2023)

Historic Asset Writedowns and Impairment for Generation Bio (GBIO) over the last 2 years, with Q4 2023 value amounting to $39000.0.

  • Generation Bio's Asset Writedowns and Impairment fell 9062.5% to $39000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $813000.0, marking a year-over-year increase of 503.88%. This contributed to the annual value of $259000.0 for FY2024, which is 56410.26% up from last year.
  • Per Generation Bio's latest filing, its Asset Writedowns and Impairment stood at $39000.0 for Q4 2023, which was down 9062.5% from $416000.0 recorded in Q4 2022.
  • Generation Bio's Asset Writedowns and Impairment's 5-year high stood at $416000.0 during Q4 2022, with a 5-year trough of $39000.0 in Q4 2023.